Home › Funds › Zweig-DiMenna Associates LLC › WGS
Zweig-DiMenna Associates LLC position in WGS
GENEDX HOLDINGS CORP · Health Care
Zweig-DiMenna Associates LLC reported holding 358,100 shares of WGS (GENEDX HOLDINGS CORP) in its Q3 2026 13F filing — a position valued at US$25.9M, representing 2.05% of its reported portfolio and ranking #14 among its reported holdings. Zweig-DiMenna Associates LLC has disclosed WGS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Zweig-DiMenna Associates LLC's WGS position evolved
Zweig-DiMenna Associates LLC first disclosed a stake in WGS in Q4 2024 at 309,500 shares (US$23.8M). The position peaked in Q2 2025 at 586,100 shares, worth US$54.1M. Across 8 filings, Zweig-DiMenna Associates LLC increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 358,100 shares valued at US$25.9M — a reduction of -213,850 shares quarter over quarter.. Notable position changes include a 100% trim in Q3 2025 (shares rose 21% over the following quarter), a 122% increase in Q1 2026 (shares rose 7% over the following quarter), a 114290% increase in Q2 2026 (shares rose 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 309.50K | $23.79M | New |
| Q1 2025 | 457.10K | $40.48M | Add |
| Q2 2025 | 586.10K | $54.10M | Add |
| Q3 2025 | 875 | $9.43M | Reduce |
| Q4 2025 | 225 | $2.93M | Reduce |
| Q1 2026 | 500 | $3.21M | Add |
| Q2 2026 | 571.95K | $39.26M | Add |
| Q3 2026 | 358.10K | $25.89M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About WGS and 13F data
WGS (GENEDX HOLDINGS CORP) is a Health Care company. 30 other funds we track also report a position in WGS — the largest reported positions include Corvex Management (US$328.5M), Casdin Capital (US$254.5M), ARK Invest (US$138.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding WGS
- Corvex Management 4.78M sh · $328.46M · Q2 2026
- Casdin Capital 3.71M sh · $254.50M · Q2 2026
- ARK Invest 1.91M sh · $138.32M · Q3 2026
- First Light Asset Management, LLC 783.92K sh · $53.82M · Q2 2026
- Deep Track Capital, LP 700.00K sh · $48.05M · Q2 2026
- Amova Asset Management Americas, Inc. 661.81K sh · $47.80M · Q3 2026
- GAGNON SECURITIES LLC 516.28K sh · $37.33M · Q3 2026
- ASHFORD CAPITAL MANAGEMENT INC 201.99K sh · $13.87M · Q2 2026
More on Zweig-DiMenna Associates LLC
FAQ
How long has Zweig-DiMenna Associates LLC held WGS?
Zweig-DiMenna Associates LLC has disclosed WGS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Zweig-DiMenna Associates LLC's current position in WGS?
As of Q3 2026, Zweig-DiMenna Associates LLC holds 358.10K shares of WGS (GENEDX HOLDINGS CORP), valued at $25.89M, representing 2.05% of its reported portfolio and ranking #14.
Has Zweig-DiMenna Associates LLC been buying or selling WGS?
In the latest 13F filing (Q3 2026), Zweig-DiMenna Associates LLC reduced its position in WGS. The position peaked in Q2 2025 at 586.10K shares.
Which other funds hold WGS?
Other major institutional holders of WGS include Corvex Management, Casdin Capital, ARK Invest, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.